Ho Lim Pak

Dr. Ho Lim Pak


Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 July 2022 in World Neurosurgery
Verified
Journal Article
Open access
HPHo Lim Pak
Ho Lim Pak
GLGiorgio Lambru
Giorgio Lambru
MOMohamed Okasha
Mohamed Okasha
EMEleni Maratos
Eleni Maratos
NTNicholas Thomas
Nicholas Thomas
SBSinan Barazi
Sinan Barazi
Microscopic microvascular decompression (MVD) of the trigeminal nerve is the gold standard surgical treatment for medically refractory classical trigeminal neuralgia. Endoscopy has significantly advanced surgery and provides enhanced visualization of the cerebellopontine angle and its critical neurovascular structures. We present our initial experience of fully endoscopic microvascular decompression (e-MVD). This retrospective case series investigated e-MVD performed from September 2016 to February 2020 at a single institution. Clinical data including presenting symptoms, medications, operative findings, postoperative complications, and outcomes were recorded. The 5-point Barrow Neurological Institute (BNI) pain intensity score was used to quantify patients' pain relief. During the study period, 25 patients with trigeminal neuralgia (10 males, 15 females; mean [SD] age = 63 [10.4] years) underwent e-MVD. All patients had a preoperative BNI score of V. The left side was affected in 15 patients. Complications occurred in 2 patients: both experienced hearing loss, and one experienced transient facial weakness 7 days after surgery. The facial weakness had resolved by the last follow-up. All patients were completely pain-free (BNI score I) immediately postoperatively. On latest follow-up, 22 patients have remained pain-free, and 3 patients have recurrent pain that is being controlled with medication (BNI score III). Our study demonstrated that e-MVD is a safe, possibly effective method of performing MVD with the added benefit of improved visualization of the operative field for the operating surgeon and the surgical team. Larger prospective studies are required to evaluate whether performing e-MVD confers any additional benefits in long-term clinical outcome of patients with trigeminal neuralgia.

30 October 2023 in Brain Sciences
Verified
Journal Article
Open access
PDF file
ISIoannis Stavropoulos
Ioannis Stavropoulos
HPHo Lim Pak
Ho Lim Pak
GAGonzalo Alarcon
Gonzalo Alarcon
AVAntonio Valentin
Antonio Valentin
Status epilepticus (SE) is a life-threatening condition and medical emergency which can have lifelong consequences, including neuronal death and alteration of neuronal networks, resulting in long-term neurologic and cognitive deficits in children. When standard pharmacological treatment for SE is not successful in controlling seizures, the condition evolves to refractory SE (rSE) and finally to super-refractory SE (srSE) if it exceeds 24 h despite using anaesthetics. In this systematic review, we present literature data on the potential uses of clinical neuromodulation techniques for the management of srSE in children, including electroconvulsive therapy, vagus nerve stimulation, and deep brain stimulation. The evaluation of these techniques is limited by the small number of published paediatric cases (n = 25, one with two techniques) in peer-reviewed articles (n = 18). Although neuromodulation strategies have not been tested through randomised, prospective controlled clinical trials, this review presents the existing data and the potential benefits of neuromodulation therapy, suggesting that these techniques, when available, could be considered at earlier stages within the course of srSE intending to prevent long-term neurologic complications. Clinical trials aiming to establish whether early intervention can prevent long-term sequelae are necessary in order to establish the potential clinical value of neuromodulation techniques for the treatment of srSE in children.

3 September 2025 in World Neurosurgery
Verified
Journal Article
Open access
SBSinan Barazi
Sinan Barazi
HPHo Lim Pak
Ho Lim Pak
EMEleni Maratos
Eleni Maratos
SCSteve Connor
Steve Connor
GLGiorgio Lambru
Giorgio Lambru
This analysis aims to evaluate the sustained effectiveness of trigeminal microvascular decompression (MVD) in patients with medically refractory short-lasting unilateral neuralgiform headache attacks (SUNHA) who demonstrate trigeminal neurovascular conflict (NVC) ipsilateral to the painful side. This is a retrospective single-center analysis of prospectively collected data conducted between September 2012 and March 2025 to investigate the efficacy and safety of trigeminal MVD in consecutive refractory chronic SUNHA patients suitable for surgery. All patients underwent a magnetic resonance imaging with specific trigeminal sequences before surgery. The 5-point Barrow Neurological Institute (BNI) pain intensity score was used to quantify the response to surgery. Patients with a BNI of 1-2 at the final postsurgery follow-up were considered responders. The study group consisted of 19 SUNHA patients (n = 7 female), with a mean age of 58 (±12, range 35-81), refractory to medical therapy (BNI score = 5), who underwent trigeminal MVD. Of the 18 patients included in the analysis, trigeminal NVC with morphological changes was found in 13 patients (72.2%). Postoperatively, 16 patients (89.0%) were responders. Two patients had a BNI score of 3, reflecting a partial improvement (11.1%). The mean postsurgery follow-up was 54.3 months (±36.7, range 2-163 months). At the final follow-up, 13 patients remained responders (72.2%). One patient reported transient postoperative dizziness, and 1 patient reported pain in the incision site. Trigeminal MVD may be a safe and effective treatment modality for those patients with medically refractory SUNHA with magnetic resonance imaging evidence of trigeminal NVC with morphological changes.